Several carpabenemase (KPC) gene mutations are associated with ceftazidime/avibactam (CAZ-AVI) resistance. Here, we describe four subsp. CAZ-AVI-resistant clinical isolates, collected at the University Hospital of Tor Vergata, Rome, Italy, from July 2019 to February 2020. These resistant strains were characterized as KPC-3, having the transition from cytosine to thymine (CAC-TAC) at nucleotide position 814, with histidine that replaces tyrosine (H272Y). In addition, two different types of KPC gene mutations were detected. The first one, common to three strains, was the D179Y (G532T), associated with CAZ-AVI resistance. The second mutation, found only in one strain, is a new mutation of the KPC-3 gene: a transversion from thymine to adenine (CTG-CAG) at nucleotide position 553. This mutation causes a KPC variant in which glutamine replaces leucine (Q168L). None of the isolates were detected by a rapid immunochromatographic assay for detection of carbapenemase (NG Biotech, Guipry, France) and were unable to grow on a selective chromogenic medium Carba SMART (bioMerieux, Firenze, Italy). Thus, they escaped common tests used for the prompt detection of KPC-producing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624296 | PMC |
| http://dx.doi.org/10.3390/microorganisms9112356 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study.
Antibiotics (Basel)
November 2024
Servicio Antimicrobianos, National Reference Laboratory in Antimicrobial Resistant, National Institute of Infectious Diseases (INEI), Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos G Malbrán", Ave. Velez Sarsfield 563, Buenos Aires City 1281, Argentina.
Unlabelled: The COVID-19 pandemic has exacerbated the global antimicrobial resistance (AMR) crisis. Consequently, it is more urgent than ever to prioritize AMR containment and support countries in improving the detection, characterization, and rapid response to emerging AMR threats. We conducted a prospective, multicenter study to assess the prevalence of carbapenemase-producing Enterobacterales in infectious processes in Argentina during the post-COVID-19 pandemic period and explore therapeutic alternatives for their treatment (RECAPT-AR study).
View Article and Find Full Text PDFCarbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022-February 2023.
Infect Dis Ther
January 2025
Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Chełmska 30/34, 00-725, Warsaw, Poland.
Introduction: Despite a scarcity of data, before 2022 Ukraine was already considered a high-prevalence country for carbapenemase-producing Enterobacterales (CPE), and the situation has dramatically worsened during the full-scale war with Russia. The aim of this study was to analyse CPEs isolated in Poland from victims of war in Ukraine.
Methods: The study included 65 CPE isolates from March 2022 till February 2023, recovered in 36 Polish medical centres from 57 patients arriving from Ukraine, differing largely by age and reason for hospitalisation.
Wastewater monitoring - passive sampling for the detection of SARS-CoV-2 and antibiotic resistance genes in wastewater.
Sci Total Environ
December 2024
TZW: DVGW-Technologiezentrum Wasser, Karlsruher Str. 84, D-76139 Karlsruhe, Germany. Electronic address:
As a lesson learned from the COVID-19 pandemic, wastewater-based epidemiology was recognised and used as an important method for surveillance and early detection of SARS-CoV-2. As a result, consideration of wastewater as a source of public health information has gained new prominence, and there is consensus that similar approaches can be used to detect the spread of other viral pathogens or antimicrobial resistance (AMR) in populations. However, the implementation of wastewater monitoring poses challenges in terms of obtaining representative and meaningful samples.
View Article and Find Full Text PDFNDM-1 and KPC-3 co-producing Klebsiella pneumoniae ST512 in bronchial secretion from a patient in an intensive care unit of a Greek Tertiary Care Hospital.
Acta Microbiol Immunol Hung
December 2024
3Hippokration General Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.
This study investigated a strain of Klebsiella pneumoniae, identified as GRTHES, which exhibited extensive antibiotic resistance. The strain was resistant to all beta-lactams, including combinations with newer agents such as meropenem/vaborbactam and imipenem/relebactam, as well as to aminoglycosides, fluoroquinolones, fosfomycin, trimethoprim-sulfamethoxazole and colistin. It remained susceptible to tigecycline.
View Article and Find Full Text PDFMultidrug-resistant ESBL-producing Klebsiella pneumoniae complex in Czech hospitals, wastewaters and surface waters.
Antimicrob Resist Infect Control
November 2024
Central European Institute of Technology, University of Veterinary Sciences Brno, Brno, Czech Republic.
Article Synopsis
- The study investigates multidrug-resistant Klebsiella pneumoniae (KpSC) in various sources, such as patients with urinary tract infections, hospital sewage, and wastewater treatment plants, highlighting the potential for spread in community environments.
- A total of 372 KpSC isolates were analyzed, revealing that 95% were present across all sampling locations, with a significant proportion resistant to critical antibiotics.
- Phylogenetic analysis identified transmission of a specific lineage (ST307) from patients to wastewater, emphasizing the interconnectedness of clinical and environmental sources of MDR bacteria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!